Atlanpole Biotherapies

📍 Nantes Cedex 3, France🗓 Founded 2005👥 13 employees💰 Last funded Jul 2024
Biotechnology Research🌐 atlanpolebiotherapies.com
Website LinkedIn
Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2005
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Atlanpole Biotherapies?
Atlanpole Biotherapies has 2 investors on record on gritt.io and 1 late-stage investors.
When did Atlanpole Biotherapies last raise funding?
The most recent investment in Atlanpole Biotherapies recorded on gritt.io was in July 2024.
When was Atlanpole Biotherapies founded?
Atlanpole Biotherapies was founded in 2005.
What industry is Atlanpole Biotherapies in?
Atlanpole Biotherapies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Atlanpole Biotherapies based?
Atlanpole Biotherapies is headquartered in Nantes Cedex 3, France.